REPLIGEN CORP (RGEN) scores 52 out of 100 on boothcheck's 11-model valuation framework. Verdict: Poor The estimated fair value is 26.09, representing a 78% premium to fair value. Quantitative score: 51/100. Qualitative score: 70/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.